Determinants of potency on α-conotoxin MII, a peptide antagonist of neuronal nicotinic receptors

被引:50
作者
Everhart, D
Cartier, GE
Malhotra, A
Gomes, AV
McIntosh, JM
Luetje, CW
机构
[1] Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33101 USA
[2] Univ Miami, Sch Med, Dept Biochem, Miami, FL 33101 USA
[3] Univ Miami, Sch Med, Dept Mol Biol, Miami, FL 33101 USA
[4] Univ Utah, Dept Biol & Psychiat, Salt Lake City, UT 84112 USA
关键词
D O I
10.1021/bi036180h
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
alpha-Conotoxin MII, a peptide toxin isolated from Conus magus, antagonizes a subset of neuronal nicotinic receptors. Rat alpha3beta2 receptors, expressed in Xenopus oocytes, are blocked with an IC50 of 3.7 +/- 0.3 nM. To identify structural features that determine toxin potency, a series of alanine-substituted toxins were synthesized and tested for the ability to block the function of alpha3beta2 receptors. Circular dichroism and protein modeling were used to assess the structural integrity of the mutant toxins. Three residues were identified as major determinants of toxin potency. Replacement of asparagine 5, proline 6, or histidine 12 with alanine resulted in >2700-fold, 700-fold, and similar to2700-fold losses in toxin potency, respectively. A decrease in pH improved toxin potency, while an increase in pH eliminated toxin blockade, suggesting that, in the active form of the toxin, histidine 12 is charged. The imidazole ring of histidine 12 protrudes from one side, while asparagine 5 and proline 6 are located at the opposite end of the toxin structure. The side chains of these three residues are exposed on the surface of the toxin, suggesting that they directly interact with the alpha3beta2 receptor.
引用
收藏
页码:2732 / 2737
页数:6
相关论文
共 20 条
[1]   Ribbons [J].
Carson, M .
MACROMOLECULAR CRYSTALLOGRAPHY, PT B, 1997, 277 :493-505
[2]   A new alpha-conotoxin which targets alpha 3 beta 2 nicotinic acetylcholine receptors [J].
Cartier, GE ;
Yoshikami, DJ ;
Gray, WR ;
Luo, SQ ;
Olivera, BM ;
McIntosh, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (13) :7522-7528
[3]   Distribution and pharmacology of α6-containing nicotinic acetylcholine receptors analyzed with mutant mice [J].
Champtiaux, N ;
Han, ZY ;
Bessis, A ;
Rossi, FM ;
Zoli, M ;
Marubio, L ;
McIntosh, JM ;
Changeux, JP .
JOURNAL OF NEUROSCIENCE, 2002, 22 (04) :1208-1217
[4]   Microwave processing of WC-Co composites and ferroic titanates [J].
Cheng, JP ;
Agrawal, DK ;
Komarneni, S ;
Mathis, M ;
Roy, R .
MATERIALS RESEARCH INNOVATIONS, 1997, 1 (01) :44-52
[5]   Nicotinic receptors at the amino acid level [J].
Corringer, PJ ;
Le Novère, N ;
Changeux, JP .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2000, 40 :431-458
[6]   Identification of residues that confer α-conotoxin-PnIA sensitivity on the α3 subunit of neuronal nicotinic acetylcholine receptors [J].
Everhart, D ;
Reiller, E ;
Mirzoian, A ;
McIntosh, JM ;
Malhotra, A ;
Luetje, CW .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (02) :664-670
[7]   ''Orphan'' alpha 6 nicotinic AChR subunit can form a functional heteromeric acetylcholine receptor [J].
Gerzanich, V ;
Kuryatov, A ;
Anand, R ;
Lindstrom, J .
MOLECULAR PHARMACOLOGY, 1997, 51 (02) :320-327
[8]   Determinants of specificity for alpha-conotoxin MII on alpha 3 beta 2 neuronal nicotinic receptors [J].
Harvey, SC ;
McIntosh, JM ;
Cartier, GE ;
Maddox, FN ;
Luetje, CW .
MOLECULAR PHARMACOLOGY, 1997, 51 (02) :336-342
[9]  
Harvey SC, 1996, J NEUROSCI, V16, P3798
[10]   Single amino acid substitutions in α-conotoxin PnIA shift selectivity for subtypes of the mammalian neuronal nicotinic acetylcholine receptor [J].
Hogg, RC ;
Miranda, LP ;
Craik, DJ ;
Lewis, RJ ;
Alewood, PF ;
Adams, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (51) :36559-36564